Recap: PTC Therapeutics Q4 Earnings

PTC Therapeutics PTCT reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

PTC Therapeutics missed estimated earnings by 23.78%, reporting an EPS of $-2.03 versus an estimate of $-1.64.

Revenue was up $46.36 million from the same period last year.

Last quarter the company missed on EPS by $0.49 which was followed by a 4.09% increase in the share price the next day.

Here's a look at PTC Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-1.40	-1.82	-1.51	-0.94
EPS Actual	-1.89	-1.68	-1.83	-1.08
Revenue Estimate	126.44M	110.50M	98.80M	111.36M
Revenue Actual	138.74M	116.68M	117.94M	118.86M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar